Literature DB >> 33969328

No end in sight for the Brazilian COVID-19 crisis.

Talha Burki.   

Abstract

Entities:  

Mesh:

Year:  2021        PMID: 33969328      PMCID: PMC8096319          DOI: 10.1016/S2666-5247(21)00095-1

Source DB:  PubMed          Journal:  Lancet Microbe        ISSN: 2666-5247


× No keyword cloud information.
As The Lancet Microbe went to press, the number of Brazilians to have died from COVID-19 had passed 350 000. Only the USA has a higher death toll. The pandemic has brought Brazil's health-care system to the verge of collapse. By the end of March, 2021, intensive care units in 17 of the country's 27 states were at more than 90% occupancy (seven others were at more than 80% occupancy). Supplies of drugs and oxygen are running short. On April 15, Médecins Sans Frontières warned of a “humanitarian catastrophe” in Brazil. The second wave of COVID-19 started to take hold in Brazil in November, 2020. The trend has been sharply upwards ever since. On a single day in March, 2021, Brazil recorded more than 100 000 new cases of the disease. On two separate days in early April, the country saw more than 4000 deaths. The P.1 variant of SARS-CoV-2 appears to be driving the surge. It is thought to be at least twice as transmissible as the wildtype strain and can infect people who have previously contracted the virus. “There seems to be a higher proportion of people who get sick after being infected, and we are also seeing more young people get very ill, very rapidly”, said Ester Sabino, associate professor in the Department of Infectious Disease at the University of São Paulo Medical School. “But we still need to figure out how much more pathogenic this variant is; it could just be that younger people are more exposed to the virus.” Brazil currently accounts for more than a quarter of the world's weekly deaths from COVID-19. Yet this is a country with universal health care, albeit with a great deal of regional variation; lengthy experience in dealing with disease outbreaks; and a well established immunisation programme. “We could have used the health system in a smart way to do contact tracing and to inform the population. But this did not happen”, explains Miguel Lago, executive director of the Institute for Health Policy Studies in Rio de Janeiro. “There has been no planning; everything is totally disorganised”, adds Sabino. “This new variant comes out from the city of Manaus [in the Brazilian Amazon], and we allowed planes to keep running out of there. There were movements of people starting the epidemic everywhere.” Surveillance efforts remain far below what is required and only 11% of Brazilians have received the first dose of the COVID-19 vaccine. “At the beginning of the pandemic, there was a lot of effort to mitigate the transmission of the virus and to reduce the mobility of the population”, recalls Daniel Villela, a research scientist at Rio de Janeiro's Fundação Oswaldo Cruz, or Fiocruz. “In bits of the country we observed flattening of the curve. But with this second wave, people are becoming fatigued with the restrictions.” Public transport is packed, as were the beaches of Rio de Janeiro, until they were finally closed late in March. “Brazil had a lot of opportunity to address the pandemic successfully”, said Lago. “We cannot blame the health system or the shortages. The man to blame is Jair Bolsonaro. He has tried to sabotage any kind of response.” The Brazilian President has called COVID-19 “a little flu”, has undermined face-masks and the vaccine, and suggested that Brazilians “stop whining” about the pandemic. He has vetoed legislation aimed at controlling the spread of SARS-CoV-2 and designated a host of services as “essential”, including gyms, leaving them exempt from any attempt to impose a lockdown. A scheme providing emergency monthly stipends for low-income families was ended in December, 2020, incentivising people to go out to work just as the second wave of COVID-19 was gathering pace. Three ministers of health have left since the start of the pandemic. “It is so easy to break the confidence in disease control measures, and this is what our President has done”, said Sabino. “His supporters will not accept any lockdown now. People are going out without any precautions.” Health in Brazil is devolved to the states and municipalities. But the central government exerts strong influence. Bolsonaro has refused to introduce a national lockdown and described governors and mayors who have done so locally as “tyrants”. Lago reckons that the President's arguments against lockdowns on economic grounds have prevailed. “Bolsonaro has won the rhetorical narrative. He has raised the political cost of imposing the kind of restrictions we need to combat COVID-19”, said Lago. “We saw in last year's municipal elections that even mayors who are in opposition to Bolsonaro are afraid of losing votes by advocating rigorous measures. That is why we have not had any true lockdown, in over a year of the pandemic. It is not politically viable. No-one is defending the idea of lockdown.” The sluggish rollout of the COVID-19 vaccines has exacerbated matters. Fiocruz has an agreement with AstraZeneca to produce their vaccine but there have been supply problems. They are still not ready to start production at scale. “Until we can get the vaccines rolled out, we need to have strict control measures for enough time that they can be effective”, said Villela. Few people expect this to happen. “With this president, it is hard to see how Brazil can come out of this crisis”, Sabino told The Lancet Microbe.
  10 in total

1.  Brief internet-delivered cognitive-behavioural intervention for children and adolescents with symptoms of anxiety and depression during the COVID-19 pandemic: a randomised controlled trial protocol.

Authors:  Caio Borba Casella; Pedro Fonseca Zuccolo; Luisa Sugaya; Aline Santana de Souza; Luara Otoch; Fernanda Alarcão; Wagner Gurgel; Daniel Fatori; Guilherme V Polanczyk
Journal:  Trials       Date:  2022-10-22       Impact factor: 2.728

2.  Impacts of a delayed and slow-paced vaccination on cases and deaths during the COVID-19 pandemic: a modelling study.

Authors:  Gustavo Barbosa Libotte; Lucas Dos Anjos; Regina Célia Cerqueira de Almeida; Sandra Mara Cardoso Malta; Roberto de Andrade Medronho
Journal:  J R Soc Interface       Date:  2022-05-25       Impact factor: 4.293

3.  Impact of the COVID-19 pandemic on publication dynamics and non-COVID-19 research production.

Authors:  Marc Raynaud; Valentin Goutaudier; Kevin Louis; Solaf Al-Awadhi; Quentin Dubourg; Agathe Truchot; Romain Brousse; Nouredine Saleh; Alessia Giarraputo; Charlotte Debiais; Zeynep Demir; Anaïs Certain; Francine Tacafred; Esteban Cortes-Garcia; Safia Yanes; Jessy Dagobert; Sofia Naser; Blaise Robin; Élodie Bailly; Xavier Jouven; Peter P Reese; Alexandre Loupy
Journal:  BMC Med Res Methodol       Date:  2021-11-22       Impact factor: 4.615

4.  Coresidence increases the risk of testing positive for COVID-19 among older Brazilians.

Authors:  Flavia Cristina Drumond Andrade; Nekehia T Quashie; Luisa Farah Schwartzman
Journal:  BMC Geriatr       Date:  2022-02-05       Impact factor: 3.921

5.  The disruption of elective procedures due to COVID-19 in Brazil in 2020.

Authors:  Gustavo Saraiva Frio; Letícia Xander Russo; Cleandro Pires de Albuquerque; Licia Maria Henrique da Mota; Adriana Ferreira Barros-Areal; Andréa Pedrosa Ribeiro Alves Oliveira; João Firmino-Machado; Everton Nunes da Silva
Journal:  Sci Rep       Date:  2022-06-29       Impact factor: 4.996

6.  COVID-19 morbidity in Afghanistan: a nationwide, population-based seroepidemiological study.

Authors:  Sayed Ataullah Saeedzai; Mohammad Nadir Sahak; Fatima Arifi; Eman Abdelkreem Aly; Margo van Gurp; Lisa J White; Siyu Chen; Amal Barakat; Giti Azim; Bahara Rasoly; Soraya Safi; Jennifer A Flegg; Nasar Ahmed; Mohmmad Jamaluddin Ahadi; Niaz M Achakzai; Alaa AbouZeid
Journal:  BMJ Open       Date:  2022-07-27       Impact factor: 3.006

7.  Risk factors for hospitalization and death due to COVID-19 among frail community-dwelling elderly people: a retrospective cohort study.

Authors:  Daniela Castelo Azevedo; Fernando César Menezes Assunção; Mônica Silva Monteiro de Castro; Estevão Alves Valle
Journal:  Sao Paulo Med J       Date:  2022 Sep-Oct       Impact factor: 1.838

8.  Impact of COVID-19 on Healthcare Workers in Brazil between August and November 2020: A Cross-Sectional Survey.

Authors:  Edlaine Faria de Moura Villela; Izadora Rodrigues da Cunha; Joseph Nelson Siewe Fodjo; Michael Obimpeh; Robert Colebunders; Stijn Van Hees
Journal:  Int J Environ Res Public Health       Date:  2021-06-17       Impact factor: 3.390

9.  Brazil and the COVID-19 Pandemic.

Authors:  Augusto Cesar Soares Dos Santos Junior
Journal:  Kidney Int Rep       Date:  2021-07-06

10.  Understanding Factors to COVID-19 Vaccine Adoption in Gujarat, India.

Authors:  Viral Tolia; Rajkumar Renin Singh; Sameer Deshpande; Anupama Dave; Raju M Rathod
Journal:  Int J Environ Res Public Health       Date:  2022-02-25       Impact factor: 3.390

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.